P1323: PREDICTION OF NON-RELAPSE MORTALITY BY EASIX AND HCT-CI SCORES IN PATIENTS WITH CHRONIC MYELOMONOCYTIC LEUKEMIA UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT

por Baranwal, A., Mangaonkar, A., Shah, M., Litzow, M., Hogan, W., Patnaik, M., Alkhateeb, H.
Publicado 2022

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

por Kenderian, S S, Al-Kali, A, Gangat, N, Letendre, L, Hogan, W J, Litzow, M R, Patnaik, M M
Publicado 2013

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

por Pardanani, A, Laborde, R R, Lasho, T L, Finke, C, Begna, K, Al-Kali, A, Hogan, W J, Litzow, M R, Leontovich, A, Kowalski, M, Tefferi, A
Publicado 2013

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

por Haddox, C L, Mangaonkar, A A, Chen, D, Shi, M, He, R, Oliveira, J L, Litzow, M R, Al-Kali, A, Hogan, W J, Elliott, M A
Publicado 2017

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

por Pardanani, A, Abdelrahman, R A, Finke, C, Lasho, T T, Begna, K H, Al-Kali, A, Hogan, W J, Litzow, M R, Hanson, C A, Ketterling, R P, Tefferi, A
Publicado 2015

Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era

por Chakraborty, R, Muchtar, E, Kumar, S K, Jevremovic, D, Buadi, F K, Dingli, D, Dispenzieri, A, Hayman, S R, Hogan, W J, Kapoor, P, Lacy, M Q, Leung, N, Gertz, M A
Publicado 2016

CD34(+) cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before...

por Holtan, S G, Hogan, W J, Elliott, M A, Ansell, S M, Inwards, D J, Porrata, L F, Johnston, P B, Micallef, I N, Lacy, M Q, Gastineau, D A, Litzow, M R
Publicado 2010

Predicting Peripheral Blood Stem Cell Harvest Failure Using Circulating CD34 Levels: Developing Target-Based Cut-Points for Early Intervention

por Sinha, S, Gastineau, D, Micallef, I, Hogan, W, Ansell, S, Buadi, F, Dingli, D, Dispenzieri, A, Gertz, M, Greiner, C, Hayman, S, Inwards, D, Johnston, P, Lacy, M, Litzow, M, Porrata, L, Winters, JL., Kumar, S
Publicado 2010

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

por Begna, K. H., Kittur, J., Gangat, N., Alkhateeb, H., Patnaik, M. S., Al-Kali, A., Elliott, M. A., Hogan, W. J., Litzow, M. R., Pardanani, A., Hanson, C. A., Ketterling, R. P., Tefferi, A.
Publicado 2022

Characterization of adult obesity in Florida using the OneFlorida clinical research consortium

por Filipp, S. L., Cardel, M., Hall, J., Essner, R. Z., Lemas, D. J., Janicke, D. M., Smith, S. R., Nadglowski, J., Troy Donahoo, W., Cooper‐DeHoff, R. M., Nelson, D. R., Hogan, W. R., Shenkman, E. A., Gurka, M. J.
Publicado 2018

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3”

por Begna, K. H., Xu, X., Gangat, N., Alkhateeb, H., Patnaik, M. M., Al-Kali, A., Elliott, M. A., Hogan, W. J., Litzow, M. R., Hook, C. C., Wolanskyj-Spinner, A. P., Mangaonkar, A., He, R., Pardanani, A., Shah, M., Ketterling, R. P., Tefferi, A.
Publicado 2022

CPT tests in the neutral kaon system

por Schwingenheuer, B, Briere, R A, Barker, A R, Cheu, E, Gibbons, L K, Harris, D A, Makoff, G, McFarland, K S, Roodman, A, Wah, Y W, Winstein, Bruce D, Winston, R, Swallow, E C, Bock, G J, Coleman, R, Crisler, M, Enagonio, J, Ford, R, Hsiung, Y B, Jensen, D A, Ramberg, E, Tschirhart, R S, Yamanaka, T, Collins, E M, Gollin, G D, Gu, P, Haas, P, Hogan, W P, Kim, S K, Matthews, J N, Myung, S S, Schnetzer, S R, Somalwar, S V, Thomson, G B, Zou, Y
Publicado 1995